Inventor · disambiguated record
Darren Schofield
Also filed as: SCHOFIELD DARREN · SCHOFIELD DARREN J
17 granted patents·7 pending applications·34 citations·filing 2000–2025
91Inventor score
Top patents by PatentIndex Score
24 records- 0193US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 0289USRE49908EBispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Apr 9, 2024·1 cites·43 claims
- 0389US11279759B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Mar 22, 2022·4 cites·19 claims
- 0487US2025074986A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0584US9884911B2Compounds and methods for treating painMEDIMMUNE LTD·Filed 2015·Granted Feb 6, 2018·4 cites·16 claims
- 0684US7635476B2Anti-hepatitis a virus antibodiesUS HEALTH·Filed 2007·Granted Dec 22, 2009·4 cites·17 claims
- 0784US7282205B2Anti-hepatitis A virus antibodiesUS HEALTH·Filed 2002·Granted Oct 16, 2007·8 cites·24 claims
- 0884US2024262902A1Compounds and methods for treating painMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 0982US11053307B2Compounds and methods for treating painMEDIMMUNE LTD·Filed 2019·Granted Jul 6, 2021·1 cites·24 claims
- 1080US10457728B2Compounds and methods for treating painMEDIMMUNE LTD·Filed 2017·Granted Oct 29, 2019·2 cites·19 claims
- 1176US2023331830A1Antibodies to alpha-synuclein and uses thereofMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1275US11897949B2Compounds and methods for treating painMEDIMMUNE LTD·Filed 2021·Granted Feb 13, 2024·0 cites·23 claims
- 1375US2022251204A1Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2021·Application pending·0 cites
- 1470US11560424B2Antibodies to alpha-synuclein and uses thereofMEDIMMUNE LTD·Filed 2020·Granted Jan 24, 2023·0 cites·35 claims
- 1570US2025263477A1Antibodies to alpha-synuclein and uses thereofMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 1669US2025084174A1Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 1765US12049506B2Therapeutic binding moleculesMEDIMMUNE LTD·Filed 2022·Granted Jul 30, 2024·0 cites·13 claims
- 1863US10889639B2Antibodies to alpha-synuclein and uses thereofMEDIMMUNE LTD·Filed 2018·Granted Jan 12, 2021·0 cites·21 claims
- 1962US7148323B2Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virusUS HEALTH·Filed 2005·Granted Dec 12, 2006·0 cites·6 claims
- 2057US11845791B2Antibodies directed against GDF-15MEDIMMUNE LLC·Filed 2022·Granted Dec 19, 2023·0 cites·9 claims
- 2157US10160800B2Antibodies to α-synuclein and uses thereofMEDIMMUNE LTD·Filed 2017·Granted Dec 25, 2018·0 cites·27 claims
- 2254US6930176B2Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virusUS SEC THE DEPT OF HEALTH & HU·Filed 2000·Granted Aug 16, 2005·0 cites·6 claims
- 2346US6924362B2Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis CUS HEALTH·Filed 2001·Granted Aug 2, 2005·0 cites·16 claims
- 2443US2011097270A1Monoclonal Antibodies That Bind or Neutralize Hepatitis B VirusSCHOFIELD DARREN J·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →